3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
50
Burkitt Lymphoma
28
Leukemia, Biphenotypic, Acute
15
Leukemia, Myeloid, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Leukemia
10
Myelodysplastic Syndromes
9
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
7
Osteosarcoma
6
Lymphoma
6
Leukemia, Myeloid, Accelerated Phase
6
Blast Crisis
6
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Graft vs Host Disease
5
Medulloblastoma
4
Down Syndrome
4
Urinary Bladder Neoplasms
3
Recurrence
3
Primary Myelofibrosis
3
Neoplasm Metastasis
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Juvenile
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Thrombocythemia, Essential
2
Rhabdoid Tumor
2
Polycythemia Vera
2
Interventions
pembrolizumab
1
Cholecalciferol
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Subcutaneous panniculitis-like T-cell lymphoma
×
Methotrexate
×
1 year
×
Clear all
No trials found.